Navigation Links
Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting

g molecules that hit vulnerable targets in endogenous apoptosis pathways to shut down cell growth and proliferation in cancer cells.

For additional information on Ascenta Therapeutics, please visit the company's website at www.ascenta.com.

Contact

Ascenta Therapeutics, Inc.
Mark Benedyk PhD
Vice President, Business Development
858-436-1200
mbenedyk@ascenta.com


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:12/17/2009)... Dec. 17 SpectraScience, Inc., (OTC Bulletin Board: ... Hitchin has issued the following letter to shareholders: ,, ... pleased to announce that through the recent closing of ... undertaking several initiatives critical to ramping our business performance ... additions to our European sales force. We are increasing ...
(Date:12/17/2009)... LOUIS, Dec. 17 Express Scripts, ... the largest pharmacy benefit management companies in ... study that examined the association of seizure ... A-rated anti-epileptic drug formulations. The study found ... drugs, including brand to generic substitution, was ...
(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...
Breaking Medicine Technology:SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 1U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 2U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 3U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 4Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel 28R 29 51884 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 2Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 3
(Date:12/17/2009)... Good Samaritan Hospital is changing the way ... the launch of the Good Samaritan Hospital Women,s Center ... designed to help treat two common medical problems - ... the bladder, uterus or rectum (pelvic organ prolapse). Three ... leakage and one out of three may experience pelvic ...
(Date:12/17/2009)... National Council on Disability (NCD) will conduct its ... Westheimer, Houston, TX, beginning at 8:30 a.m. on Tuesday, ... Thursday, January 21, 2010. This meeting is open to ... to hear from communities around the country on what ... This meeting will provide another opportunity for that exchange. ...
(Date:12/17/2009)... Data from a recent Thomson Reuters study show that ... papers in 1998 to nearly 112,000 in 2008. ... 2% of the biomedical literature, has evaluated more than ... While only 27 Chinese-authored papers were selected in 2004, ... set to be even higher in 2009. , Jane ...
(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...
(Date:12/17/2009)... The SMARTROLLER®, from OPTP is a uniquely designed, extremely resilient, ... that is flatter and one side that is rounder, making ... , ... Minneapolis, MN (PRWEB) December 17, ... uniquely designed, extremely resilient, ‘two-in-one’ foam roller. This patented foam ...
Breaking Medicine News(10 mins):Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:China rapidly catching up in research impact 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:OPTP Introduces the SMARTROLLER 2
... vitally important in the fight against HIV and they ... work, according to a new commentary published today in ... Imperial College London, who are evaluating multiple candidate vaccines ... funding agencies must commit to sharing technology and expertise ...
... still do not know what causes epileptic seizures, but ... closer to solving this puzzle with the help of ... is the first human genetic mutation based mouse model ... The mouse is now helping Dr Steven Petrou and ...
... California seniors finds too few health tests , MONDAY, ... received by vulnerable elderly Medicare, Medicaid patients is barely ... at the University of California, Los Angeles, used quality ... Vulnerable Elders project to look at 43 specific types ...
... Quarter of 2007; Company Prepares for ... Integration of Organon BioSciences, KENILWORTH, ... reported financial results for the third,quarter of 2007 and commented ... the Organon human health business,and Intervet animal health business. ...
... settlement agreement with Teva, TOKYO, BRISTOL, ... Inc. ("Astellas"; headquarters: Tokyo; President and CEO: ... and Teva,Pharmaceutical Industries Ltd. ("Teva" Nasdaq: TEVA) ... with Item Development AB ("Item") and,King have ...
... study finds that survival for elderly patients with lung ... expenditures for lung cancer treatment. The study by Harvard ... Research researchers, published in the December 1, 2007 issue ... Society, finds that average life-expectancy rose by less than ...
Other Medicine News:Health News:Fight against HIV needs local scientists, say researchers 2Health News:Childhood epilepsy research offers new hope for seizure control 2Health News:Most Elderly Don't Get Good Medical Care: Study 2Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 2Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 3Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 4Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 5Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 6Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 7Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 8Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 9Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 10Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 11Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 12Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 13Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 14Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 15Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 16Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 17Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 18Health News:Adenoscan(R) Patent Lawsuits Settled 2Health News:Adenoscan(R) Patent Lawsuits Settled 3Health News:Adenoscan(R) Patent Lawsuits Settled 4Health News:Spending more for lung cancer treatment did not substantially increase patients' lives 2
... a qualitative enzyme immunoassay (EIA) that ... capsid antigen (EBV-VCA), Epstein-Barr early nuclear ... When used in conjunction with Mono-M ... the serodiagnosis of infectious (EBV) mononucleosis ...
... an ELISA method for the qualitative detection of ... (VCA) in human serum. When the VCA IgG ... such as the EBV nuclear antigen (EBNA-1), VCA ... tests, the results can serve as an aid ...
... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...
Medicine Products: